OFATUMUMAB vs UBLITUXIMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
OFATUMUMAB vs UBLITUXIMAB: Safety Overview
| Metric | OFATUMUMAB | UBLITUXIMAB |
|---|---|---|
| Total FAERS Reports | 29,913 | 1,582 |
| Deaths Reported | 695 | 27 |
| Death Rate | 2.3% | 1.7% |
| Hospitalizations | 3,616 | 213 |
| Average Patient Age | 47.5 yrs | 49.7 yrs |
| % Female Patients | 74.9% | 73.4% |
| Manufacturer | Novartis Pharmaceuticals Corporation | TG Therapeutics, Inc. |
| Route | INTRAVENOUS | INTRAVENOUS |
| Marketing Status | Prescription | N/A |